HgbA1C, Glycosylated Hemoglobin and Normal A1c

Diabetes Lab Tests, Doctablet Diabetes 2 Comments

Hemoglobin A1c, HgbA1C , glycosylated hemoglobin or A1c for short, gives you a picture of your average blood sugar over 2 to 3 months. Red blood cells are tiny flexible discs responsible for carrying fresh oxygen throughout the body. Oxygen binds to hemoglobin, a special protein within these cells. Red blood cells are designed to CARRY oxygen, not burn it, so instead they rely on sugar for the energy they use to travel.

Advertisement

HgbA1c, HbA1c measures how much sugar is attached to red blood cells.

To better understand the HgbA1c test, also known as glycosylated hemoglobin, you will need to remember the last time you ate fried dough at the county fair. For your enjoyment, small, delicious pieces of fried dough are thrown into a greasy paper bag with loads of powdered sugar. The bag is shaken up, mixing the sugar and the dough together, coating the dough with a sweet amount of sugary goodness. The more sugar added to the bag, the thicker the powdered coating will be. Your red blood cell is no different than a yummy dough ball! The more sugar the cell is exposed to, the more sugar that will attach to it over time.

Because we know that the red blood cell lives approximately 3 months, when we measure how much sugar has attached to it, doctors can estimate the average blood sugar over an extended period of time. This makes the HgbA1C a much better test than a finger stick.

Your HgbA1C can be used to estimate your average daily blood sugar level

(input your HgbA1C level into this calculator)

A1C Levels for diabetics:

Normal A1c is considered anything equal or under 5.6%. Pre-diabetes is diagnosed when the A1C value falls between 5.7 and 6.4%. Diabetes is diagnosed when the test is 6.5% or higher.
A1c levels for diabetics: Normal A1C is 5.6 and below.
About the Author
blank

Chris Palmeiro D.O. M.Sc.

Twitter

Dr. Christopher Palmeiro serves as the Medical Director of Telehealth for Moonlighting Solutions.  He is also the Medical Director of the Inpatient Endocrinology Telemedicine Program at Atlanticare Regional Medical Center in Southern New Jersey.  Additionally, Dr. Palmeiro serves Native American patients, in the Midwestern United States, via the Avera E-Care Specialty Telemedicine platform. Prior to his current positions, Dr. Palmeiro completed his fellowship in endocrinology, diabetes, and metabolism at Westchester Medical Center. He completed both his residency and chief residency in internal medicine at St. Vincent’s Catholic Medical Center in Manhattan. He is a diplomate of the American Board of Internal Medicine.  Dr. Palmeiro completed a Master of Science degree in clinical nutrition while in medical school at New York Institute of Technology College of Osteopathic Medicine and was the first graduate of an innovative program that incorporated this degree into the medical school curriculum, earning him the John J. Theobald Graduate Achievement award.  

Rate this tablet:
Click to rate this post!
[Total: 25 Average: 3.7]
Last Modified: Apr 2, 2021 @ 9:16 pm

Share this with a patient or friend

Advertisement

0 0 votes
Article Rating
Subscribe
Notify of
guest

This site uses Akismet to reduce spam. Learn how your comment data is processed.

2 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
blank
Admin
5 years ago

Personally, I do not approach “pre-diabetes” as a separate entity to diabetes. The pathological processes in pre-diabetes are the same as those in diabetes. The difference is in the size of the problem. This is why I propose the use of “small diabetes” instead of “pre-diabetes”.. The term “pre-diabetes” comes from a period in time where the only drugs available to treat diabetes caused significant amounts of hypoglycemia. Hypoglycemia is a dangerous issue that should be avoided at all costs. Treating “small diabetes” with these drugs was dangerous because of the risk of hypoglycemia, so “lifestyle changes” where the only… Read more »